XT
OKUR

XTX Topco’s OnKure Therapeutics OKUR Stock Holding History

XTX Topco’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.4K Sell
16,970
-17,159
-50% -$73.6K ﹤0.01% 3603
2026
Q1 		$141K Buy
34,129
+16,328
+92% +$50.4K ﹤0.01% 2983
2025
Q4 		$51.6K Buy
+17,801
New +$53.3K ﹤0.01% 2825
2025
Q3 		– Sell
-10,643
Closed -$25.4K – 3457
2025
Q2 		$25.4K Buy
+10,643
New +$27.9K ﹤0.01% 2131
2025
Q1 		– Sell
-18,633
Closed -$160K – 3255
2024
Q4 		$160K Buy
+18,633
New +$282K 0.01% 1639

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's OKUR Position: Q2 2026 in Review

XTX Topco reduced its OnKure Therapeutics (OKUR) stake by 50% in Q2 2026, selling an estimated $73.6K and leaving 16,970 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3603.

XTX Topco first reported a position in OKUR in Q4 2024 and has held it in 5 quarters since. The position peaked at $160K in Q4 2024. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • XTX Topco held 16,970 shares of OnKure Therapeutics worth $77.4K as of Q2 2026.
  • XTX Topco sold 17,159 OnKure Therapeutics shares in Q2 2026, an estimated $73.6K.
  • OnKure Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3603 holding.
  • XTX Topco first reported a position in OnKure Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • XTX Topco's OnKure Therapeutics position peaked at $160K in Q4 2024.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.